Shoulder Innovations (SI) closed on an oversubscribed $42 million Series D financing. The additional resources enable SI to accelerate the expansion of their commercial and distribution operations, responding to the widespread interest in its product platform.
SI has developed and commercialized various components for the InSet system, which includes the InSet Glenoid, Humeral Short Stem, Reverse and Stemless components.
Matt Ahearn, Chief Operating Officer of Shoulder Innovations, said, “Over the past 24 months, the Shoulder Innovations team has done an excellent job preparing the business to scale. The product platform, systems, and distribution foundation are in place, and we have validated the demand for our products. The Series D financing enables Shoulder Innovations to accelerate the demand with significant investments into the commercial & distribution organization, in addition to the growth of instrumentation and implants to serve the needs of our clinician partners.”
Shoulder Innovations (SI) closed on an oversubscribed $42 million Series D financing. The additional resources enable SI to accelerate the expansion of their commercial and distribution operations, responding to the widespread interest in its product platform.
SI has developed and commercialized various components for the InSet system, which...
Shoulder Innovations (SI) closed on an oversubscribed $42 million Series D financing. The additional resources enable SI to accelerate the expansion of their commercial and distribution operations, responding to the widespread interest in its product platform.
SI has developed and commercialized various components for the InSet system, which includes the InSet Glenoid, Humeral Short Stem, Reverse and Stemless components.
Matt Ahearn, Chief Operating Officer of Shoulder Innovations, said, “Over the past 24 months, the Shoulder Innovations team has done an excellent job preparing the business to scale. The product platform, systems, and distribution foundation are in place, and we have validated the demand for our products. The Series D financing enables Shoulder Innovations to accelerate the demand with significant investments into the commercial & distribution organization, in addition to the growth of instrumentation and implants to serve the needs of our clinician partners.”
Copy to clipboard 
